Expression of keratinocyte growth factor and its receptor in human breast cancer

British Journal of Cancer

Volumn 75, Issue 11, 1997, Pages 1567-1574

  Bansal, G S ^a   Cox, H C ^a   Marsh, S ^a   Gomm, J J ^a   Yiangou, C ^a   Luqmani, Y ^a   Coombes, R C ^a   Johnston, C L ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

FGF7; Fibroblast growth factor receptor 2; Human breast cancer; Keratinocyte growth factor

Indexed keywords

ESTROGEN RECEPTOR; FIBROBLAST GROWTH FACTOR 1; FIBROBLAST GROWTH FACTOR 2; FIBROBLAST GROWTH FACTOR 3; FIBROBLAST GROWTH FACTOR 4; GROWTH FACTOR RECEPTOR; KERATINOCYTE GROWTH FACTOR; MESSENGER RNA;

ADULT; AGED; ARTICLE; BREAST; BREAST CANCER; BREAST REDUCTION; CANCER CELL CULTURE; CANCER GROWTH; CELL DIVISION; CELL POPULATION; CELL PROLIFERATION; CELL STIMULATION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; FEMALE; FIBROBLAST; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MYOEPITHELIUM CELL; POSTMENOPAUSE; PREMENOPAUSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SOUTHERN BLOTTING;

EID: 0030915888     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1997.269     Document Type: Article

References (44)

1. Adnane J, Gaudray P, Dionne CA, Crumley G, Jaye M, Schlessinger J, Jeanteur P, Birnbaum D and Theillet C (1991) Bek and Flg, two receptors to members of the FGF family, are amplified in subsets of human breast cancer. Oncogene 6: 659-663
2. Alarid E, Rubin J, Young P, Chedid M, Ron D, Aaronson S and Cunha G (1994) Keratinocyte growth factor functions in epithelial induction during seminal vesicle development. Proc Natl Acad Sci USA 91: 1074-1078
3. Anandappa SY, Winstanley JHR, Leinster S, Green B, Rudland PS and Barraclough R (1994) Comparative expression of fibroblast growth factor mRNAs in benign and malignant breast disease. Br J Cancer 69: 772-776
4. Bansal G, Yiangou C, Coope RC, Gomm JJ, Luqmani YA, Coombes RC and Johnston CL (1995) Expression of fibroblast growth factor 1 is lower in breast cancer than in the normal human breast. Br J Cancer 72: 1420-1426
5. Basilico C and Moscatelli D (1992) The FGF family of growth factors and oncogenes. Adv Cancer Res 59: 115-165
6. Brauchle M, Angemeyer K, Hubner G and Werner S (1994) Large induction of keratinocyte growth factor expression by serum growth factors and proinflammatory cytokines in cultured fibroblasts. Oncogene 9: 3199-3204
7. Chirgwin SM, Przybyla AE, Macdonald RJ and Rutter WJ (1979) Isolation of biologically active ribonucleic acid from sources enriched in ribonucleases. Biochemistry 18: 5294-5299
8. Chomczynski P and Saachi N (1987) Single-step method of RNA extraction by acid guanidinium thiocyanate phenol-chloroform extraction. Anal Biochem 162: 156-159
9. Church GM and Gilbert W (1984) Genomic sequencing. Proc Natl Acad Sci USA 81: 1991-1995
10. Cullen KJ, Lippman ME, Chow D, Hill S, Rosen N and Zwiebel AE (1992) Insulin-like growth factor II overexpression in MCF-7 cells induces phenotypic changes associated with malignant progression. Mol Endocrinol 6: 91-100
11. Feinberg AP and Vogelstein B (1983) A technique for radiolabelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 132: 6-13
12. Finch PW, Rubin JS, Miki T, Ron D and Aaronson SA (1989) Human KGF is FGF-related with properties of a paracrine effector of epithelial cell growth. Science 245: 752-755
13. Finch PW, Cunha GR, Rubin JS, Wong J and Ron D (1995) Pattern of keratinocyte growth factor and keratinocyte growth factor receptor expression during mouse fetal development suggests a role in mediating morphogenetic mesochymal-epithelial interactions. Dev Dynam 203: 223-240
14. Gomm JJ, Smith J, Ryall G, Baillie R, Turnbull L and Coombes RC (1991) Localisation of basic fibroblast growth factor and transforming growth factor β1 in the human mammary gland. Cancer Res 51: 4685-4692
15. Gomm JJ, Browne P, Coope R, Liu QY, Buluwela L and Coombes RC (1995) Isolation of pure populations of epithelial and myoepithelial cells from the normal human mammary gland using immunomagnetic separation with Dynabeads. Anal Biochem 226: 91-99
16. Hofland LJ, Van Der Berg B, Van Eijck CHJ, Sprij DM, Van Koetsveld PM and Lamberts SWJ (1995) Role of tumour-derived fibroblasts in the growth of primary cultures of human breast cancer cells; somatostatin analogue octreotide. Int J Cancer 60: 93-99
17. Imagawa W, Cunha GR, Young P and Nandi S (1994) Keratinocyte growth factor and acidic fibroblast growth factor are mitogens for primary cultures of mammary epithelium. Biochem Biophys Res Commun 204: 1165-1169
18. Jaakkola S, Salmikangas P, Nylund S, Partanen J, Armstrong E, Pyronen S, Lehtovirta P and Nevanlinna H (1993) Amplification of FGFR-4 gene in human breast and gynaecological cancers. Int J Cancer 54: 378-382
19. Jaye M, Schlessinger J and Dionne C (1992) Fibroblast growth factor receptor tyrosine kinases: molecular analysis and signal transduction. Biochim Biophys Acta 1135: 185-199
20. Koji T, Chedid M, Rubin JS, Slaydon OD, Csaky KG, Aaronson SA and Brener RM (1994) Progesterone-dependent expression of KGF mRNA in stromal cells of the primate endometrium: KGF as a progestomedin. J Cell Biol 125: 393-401
21. Lehtola L, Partanen J, Sistonen L, Korhonen J, Warri A, Harkonen P, Clarke R and Alitalo K (1992) Analysis of tyrosine kinase mRNAs expressed in MCF7 breast cancer cells. Int J Cancer 50: 598-603
22. Luqmani YA, Graham M and Coombes RC (1992) Expression of basic fibroblast growth factor, FGFR-1 and FGFR-2 in normal and malignant human breast and comparison with other normal tissues. Br J Cancer 66: 273-280
23. Luqmani YA, Mortimer C, Yiangou C, Johnston CL, Bansal GS, Sinnett D, Law M and Coombes RC (1995) Expression of 2 variant forms of fibroblast growth factor receptor 1 in human breast. Int J Cancer 64: 274-279
24. Luqmani YA, Bansal GS, Mortimer C, Buluwela L and Coombes RC (1996) Expression of FGFR2 BEK and K-SAM mRNA variants in normal and malignant human breast. Eur J Cancer 32A: 518-524
25. McLeskey SW, Ding JYF, Lippman ME and Kern FG (1994) MDA-MB-134 breast carcinoma cells overexpress fibroblast growth factor receptors and are growth inhibited by FGF ligands. Cancer Res 54: 523-530
26. Miki T, Fleming TP, Bottaro DP, Rubin JS, Ron D and Aaronson SA (1991) Expression cDNA cloning of the KGF receptor by creation of a transforming autocrine loop. Science 251: 72-75
27. Miki T, Bottaro DP, Fleming TP, Smith CL, Burgess WH, Chan AM and Aaronson SA (1992) Determination of ligand-binding specificity by alternative splicing: two distinct growth factor receptors encoded by a single gene. Proc Natl Acad Sci USA 89: 246-250
28. Miyamoto M, Naruo K, Seko C, Matsumoto S, Kondo T and Kurokawa T (1993) Molecular cloning of a novel cytokine cDNA encoding the ninth member of the fibroblast growth factor family, which has a unique secretion property. Mol Cell Biol 13: 4251-4259
29. Pekonen F, Nyman T and Rutanen EM (1993) Differential expression of keratinocyte growth factor and its receptor in the human uterus. Mol Cell Endocrinol 95: 43-49
30. Penault-Llorca F, Bertucci F, Adelaide J, Pare P, Coulier F, Jacquemier J, Birnbaum D and Delapeyrier O (1995) Expression of FGF and FGF receptors in human breast cancer. Int J Cancer 61: 170-176
31. Ryan MC, Orr DJA and Horgan K (1993) Fibroblast stimulation of breast cancer cell growth in a serum-free system. Br J Cancer 67: 1268-1273
32. Savagner P, Valles AM, Jouanneau J, Yamada KM and Thiery JP (1994) Alternative splicing in fibroblast growth factor receptor 2 is associated with induced epithelial-mesenchymal transition in rat bladder carcinoma cells. Mol Cell Biol 5: 851-862
33. Siddiqi I, Funatomi H, Kobrin MS, Friess H, Buchler MW and Korc M (1995) Increased expression of keratinocyte growth factor in human pancreatic cancer. Biochem Biophys Res Commun 215: 309-315
34. Singer C, Rasmussen A, Smith HS, Lippman ME, Lynch HT and Cullen KJ (1995) Malignant breast epithelium selects for insulin-like growth factor II expression in breast stroma: evidence for paracrine function. Cancer Res 55: 2448-2454
35. Skehan P, Storeng R, Scudiero D, Monks A, McMahon J, Vistica D, Warren JT, Bokesch H, Kenney S and Boyd MR (1990) New colorimetric cytotoxicity assay for anticancer-drug screen. J Natl Cancer Inst 82: 1107-1112
36. Smola H, Thiekotter G and Fusenig NE (1993) Mutual induction of growth factor gene expression by epidermal-dermal cell interaction. J Cell Biol 122: 417-429
37. Stampfer M, Hallowes RC and Hackett AJ (1980) Growth of normal human mammary cells in culture. In vitro 16: 415-425
38. Yi ES, Bedoya AA, Lee H, Kim S, Housley RM, Aukerman SL, Tarpley JE, Starnes C, Yin S and Pierce GF (1994) Keratinocyte growth factor causes dilation of the mammary glands of mice. Interactions of keratinocyte growth factor, oestrogen and progesterone in vivo. Am J Pathol 145: 1015-1022
39. Tanaka A, Miyamoto K, Minamino N, Takeda M, Sato B, Matsuo H and Maysumoto K (1992) Cloning and characterisation of an androgen-dependent growth of mammary carcinoma cells. Proc Natl Acad Sci USA 89: 8928-8932
40. Van Roozendaal CEP, Van Ooijen B, Klijn JGM, Classen C, Eggermont AMM, Henzen-Logmans SC and Foekens JA (1992) Stromal influences on breast cancer cell growth. Br J Cancer 65: 77-81
41. Wilson SE, Weng J, Chwang EL, Gollahon L, Leitch AM and Shay JW (1994) Hepatocyte growth factor (HGF), keratinocyte growth factor (KGF) and their receptors in human breast cells and tissues: alternative receptors. Cell Mol Biol Res 40: 337-350
42. Yan G, Fukabori Y, Nikolaropoulos S, Wang F and McKeehan WL (1992) Heparin-binding keratinocyte growth factor is a candidate stromal to epithelial cell andromedin. Mol Endocrinol 6: 2123-2128
43. Yayon A, Zimmer Y, Shen GH, Avivi A, Yarden Y and Givol D (1992) A confined variable region confers ligand specificity on fibroblast growth factor receptors: implications for the origin of the immunoglobulin fold. EMBO J 11: 1885-1890
44. Yiangou C, Johnston CL, Luqmani YA, Coope RC, Gomm JJ, Law M, Shousha S and Coombes RC (1997) Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance. Br J Cancer 75: 28-33